News

AddToAny

Google+ Facebook Twitter Twitter

Scholarship now open for entries

IBMS members are being encouraged to apply for the Carol Briggs-Smalley Scholarship.

Books and mortarboard icon

Haematology laboratory scientists and technologists can apply for the chance to secure up to €5000 in funding for their research project.

The scholarship was established by the International Council for Standardisation in Haematology (ICSH) in memory of Carol Briggs-Smalley, an IBMS member and haematologist biomedical scientist.

The successful scientists will have the chance to attend and present their project at an international meeting.

Preference will be given to a standardisation project.  

For more information about the scholarship and to apply online, see the ICSH website. Applications close 1 March 2018.

Visit bit.ly/BS_CBSscholarship

Related Articles

girl computer_CREDIT_shutterstock-58872785

Gamification in biomedical science education

Senior Lecturer in Biomedical Science Jen May outlines the successful implementation of scenario-based learning software.

web_blood-testing_credit_istock-1384651794.png

SPONSORED: The power of automated gel-based ID-cards in routine immunohematology workflows

Immuno-haematology assays are pivotal to the carrying out of blood grouping, antibody screening and transfusions, and represent a critically time-dependent stage in the patient management pathway.

Technician holding a blood sample ready for testing with other human medical samples in the background.-Image credit - Science-Photo-Library-f0243823

Machine learning tool to detect cancer via liquid biopsy

US researchers have developed and tested an innovative machine-learning approach that could one day enable the earlier detection of cancer in patients by using smaller blood draws.

multiple myelomatosis-CREDIT-Science Photo Library-m132099

IBMS research grants

We look at the work of Dr Mosavar Farahani who received an IBMS Research Grant in 2023 to help fund her work on disease progression and skeletal complications in multiple myeloma.

Top